The HSA affinity of warfarin and flurbiprofen determined by fluorescence anisotropy measurements of camptothecin

BioSystems

Volumn 94, Issue 3, 2008, Pages 258-262

  Wybranowski, Tomasz ^a   Cyrankiewicz, Michał ^a   Ziomkowska, Blanka ^a   Kruszewski, Stefan ^a  

^a Biophysics Department   (Poland)

Author keywords

Affinity; Camptothecin; Fluorescence anisotropy; Flurbiprofen; Human serum albumin (HSA); Ibuprofen; Warfarin

Indexed keywords

CAMPTOTHECIN; CARBOXYLIC ACID; FLURBIPROFEN; HUMAN SERUM ALBUMIN; IBUPROFEN; WARFARIN;

DRUG; FLUORESCENCE; ORGANIC COMPOUND; PROTEIN; SERUM;

ANISOTROPY; ARTICLE; BINDING AFFINITY; DRUG BINDING SITE; DRUG PROTEIN BINDING; FLUORESCENCE; HUMAN;

EID: 54949157509     PISSN: 03032647     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biosystems.2008.05.034     Document Type: Article

References (17)

1. Bertucci C., Andrisano V., Gotti R., and Cavrini V. Use of an immobilised human serum albumin HPLC column as a probe of drug-protein interactions: the reversible binding of valproate. J. Chromatogr. B 768 (2002) 147-155
2. Birkett D.Ł. Drug protein binding. Aust. Prescribe 15 (1992) 56-57
3. Burke T.G., and Mi Z. The structural basis of camptothecin interactions with human serum albumin: impact on drug stability. J. Med. Chem. 37 (1994) 40-46
4. Burke T.G., and Tritton T.R. Structural basis of anthracycline selectivity for unilamellar phosphatidylcholine vasicles: an equilibrium binding study. Biochemistry 24 (1985) 1768-1776
5. Kober A., and Sjöholm I. The binding sites on human serum albumin for some nonsteroidal antiinflammatory drugs. Mol. Pharmacol. 18 (1980) 421-426
6. Kragh-Hansen U., Hellec F., de Foresta B., le Maire M., and Moller J.V. Detergents as probes of hydrophobic binding cavities in serum albumin and other water-soluble proteins. Biophys. J. 80 (2001) 2898-2911
7. Kragh-Hansen U., Chuang V.T.G., and Otagiri M. Practical aspects of the ligand-binding and enzymatic properties of human serum albumin. Biol. Pharm. Bull. 25 (2002) 695-704
8. Lakowicz J.R. Principles of Fluorescence Spectroscopy (1999), Kluwer Academic/Plenum Publishers, New York pp. 291-303
9. Liu X., Song D., Zhang Q., Tian Y., Liu Z., and Zhang H. Characterization of drug-binding levels to serum albumin using a wavelength modulation surface plasmon resonance sensor. Sens. Actuat. 117 (2006) 188-195
10. Mandula H., Mohan J., Parepally R., Feng R., and Smith Q.R. Role of site-specific binding to plasma albumin in drug availability to brain. J. Pharmacol. Exp. Therap. Fast Forward 317 (2006) 667-675
11. Mi Z., and Burke T.G. Differential interactions of camptothecin lactone and carboxylate forms with human blood componensts. Biochemistry 33 (1994) 10325-10336
12. Ni Y., Su S., and Kokot S. Spectrofluorimetric studies on the binding of salicylic acid to bovine serum albumin using warfarin and ibuprofen as site markers with the aid of parallel factor analysis. Anal. Chim. Acta 580 (2006) 206-215
13. Patonay G., Salon J., Sowell J., and Strekowski L. Noncovalent labeling of biomolecules with red and near-infrared dyes. Molecules 9 (2004) 40-49
14. Rahman M.M., Rahman M.H., and Rahman N.N. Competitive binding of ibuprofen and naproxen to bovine serum album: modified form of drug-drug displacement interaction at the binding site. Pak. J. Pharm. Sci. 18 (2005) 43-47
15. Sjöholm I., Ekman B., Kober A., Ljungstedt-Pahlman I., Seiving B., and Sjodin T. Binding of drugs to human serum albumin. XI. The specificity of three binding sites as studied with albumin immobilized in microparticles. Mol. Pharmacol. 16 (1979) 767-777
16. Sudlow G., Birkett D.J., and Wade D.N. The characterization of two specific drug binding sites on human serum albumin. Mol. Pharmacol. 11 (1975) 824-832
17. Ziomkowska B., Cyrankiewicz M., and Kruszewski S. Determination of hydroxycamptotehcin affinities to albumin and membranes by steady-state fluorescence anisotropy measurements. Comb. Chem. High Thr. Screen. 10 (2007) 486-492